Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 14/05/2026			5-day change	1st Jan Change
12.48 ^CNY	-3.93%		-6.38%	-12.11%

04-28	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-17	Shenzhen YHLO Biotech receives notice of administrative penalty from regulator	RE

Suzhou Haohai Medical Treatment Technology Co., Ltd. announced that it has received funding from a group of investors

Published on 03/01/2026

S&P Capital IQ

SHENZHEN YHLO BIOTECH CO., LTD.

-3.93%

Suzhou Haohai Medical Treatment Technology Co., Ltd. announced that it has raised hundreds of millions of CNY in a round of funding co-led by new investors Efung Capital, Shenzhen YHLO Biotech Co., Ltd., and returning investors Ventech China Ltd., and Borchid Capital on March 2, 2026. The transaction included participation from new investor, Suzhou Wujiang Dongfang State-owned Capital Investment and Management Co., Ltd., and returning investors GSR Ventures Management Co. Ltd., and Tongji Alumni Fund.

The company will issue Convertible Preferred Stock in the transaction.

Latest news about Shenzhen YHLO Biotech Co., Ltd.

04-28	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-17	Shenzhen YHLO Biotech receives notice of administrative penalty from regulator	RE
03-02	E-Health Now LLC announced that it has received funding from a group of investors	CI
03-01	Suzhou Haohai Medical Treatment Technology Co., Ltd. announced that it has received funding from a group of investors	CI
03-01	Huamei Haolian Medical Technology Co., Ltd. announced that it has received funding from a group of investors	CI
02-27	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-07	YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink	MT
12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT
12-16	Shenzhen YHLO Biotech Gets Chinese Provincial Regulator's Approval for Two Autoimmune Disease Testing Kits	MT
11-28	YHLO Biotech Gets Dutch Certification for HIV Kit	MT
11-26	YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer	MT
11-20	Shenzhen YHLO Biotech Gets Guangdong Approval for Immunoassay Analyzer	MT
11-18	Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit	MT
11-07	YHLO Biotech Gets Registration Certificate for Human Chorionic Gonadotropin Kit	MT
29/10/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Chart Shenzhen YHLO Biotech Co., Ltd.

Duration

Period

688575: Dynamic Chart

Company Profile

Shenzhen YHLO Biotech Co Ltd is a China-based company primarily engaged in the provision of in vitro diagnostic instruments. The Company mainly focuses on the research, development, production, and sales of in vitro diagnostic instruments and related reagents based on chemiluminescence immunoassay, as well as the agency sales of some non-self-produced medical device products. The Company's products are used in fields such as autoimmunity, reproductive health, diabetes, and infectious diseases. The Company's products are sold in domestic and international markets.

Employees

1,678

Sector

Medical Equipment, Supplies & Distribution

More about the company